Arsenic Trioxide
NDC 25021-226, Arsenic Trioxide, injection, from Sagent Pharmaceuticals.
- Product NDC
- 25021-226
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215059
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-226 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ARSENIC TRIOXIDE1 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-226-10 | 25021022610 | 10 VIAL in 1 CARTON (25021-226-10) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7fe0fe9f-e87b-44ab-b92c-9b3d23942063Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25021-226
Use it
Look up 25021-226 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-226 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-226. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.